This study investigated the possible therapeutic effects of oral rifampin on patients with acute Central Serous Chorioretinopathy (CSC). clinical trial was a randomized placebo-controlled, double-masked research involving 30 CSC. The were randomly assigned into two groups, one receiving 600 mg once day for month and another being matched placebo group. Best Corrected Visual Acuity (BCVA), subre...
